ArticleCell and tissue research2025

Nanobody-based Pannexin1 channel inhibitors increase survival after cardiac ischemia/reperfusion.

Olga M Rusiecka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.